New drugs for old? What is the role of B-cell receptor pathway inhibition in the front line therapy of CLL in 2017?
EHA Learning Center. Devereux S. Jun 25, 2017; 184552
Topic: 3Aj Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Stephen Devereux
Stephen Devereux

Access to EHA Members only content is an EHA membership benefit. Click here to join EHA or renew your membership here.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions